Sex differences in the aversive effects of kappa-opioid receptor activation

κ-阿片受体激活的厌恶效应存在性别差异

• 批准号: 8444087
• 负责人: ELENA H CHARTOFF
• 金额: $ 7.9万
• 依托单位: MCLEAN HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-01-01 至 2014-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8444087
• 关键词: Address; Affect; Affective; Agonist; Alcohol abuse; Anhedonia; Attenuated; Behavior; Behavioral; Binding; Biological; Brain; Brain region; Cavia; Chronic; Coupling; Data; Dependence; Drug Addiction; Drug abuse; Dynorphins; Exposure to; FOS gene; Female; Foundations; Future; GRK; Gender Role; Goals; Gonadal Hormones; Gonadal Steroid Hormones; Human; Hypothalamic structure; In Situ Hybridization; Intake; Knowledge; Laboratories; Laboratory Animals; Lead; Ligands; Link; Measurement; Mediating; Mental Depression; Messenger RNA; Molecular; Nature; Neuropeptides; Operant Conditioning; Opioid; Outcome; Pathway interactions; Pharmaceutical Preparations; Pharmacodynamics; Phase; Phosphorylation; Pilot Projects; Play; Procedures; Rattus; Receptor Activation; Regulation; Relapse; Reporting; Research; Rewards; Rodent; Role; Self Stimulation; Sex Characteristics; Stimulus; Stress; Structure of terminal stria nuclei of preoptic region; System; Testing; Time; TimeLine; Training; Western Blotting; Woman; Writing; addiction; base; craving; depressive symptoms; disturbance in affect; drug addict; drug of abuse; drug withdrawal; effective therapy; immunoreactivity; indexing; kappa opioid receptors; mRNA Expression; male; men; mood regulation; negative emotional state; neuroadaptation; paraventricular nucleus; prodynorphin; public health relevance; receptor; receptor function; research and development; response; sex

DESCRIPTION (provided by applicant): This R03 proposal was written in response to PA-11-049, "Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence". Growing evidence shows that drug-dependent women express greater negative affect than men (1, 2, 3, 4) and negative emotional states such as stress and depression are more likely to trigger craving and relapse in women (5, 6). Research in males has shown that aversive and depressive-like states are mediated, in part, by the neuropeptide dynorphin, an endogenous ligand that acts at kappa opioid receptors (7). Chronic exposure to drugs of abuse promotes the synthesis and release of dynorphin that is coincident with the emergence of depressive-like effects (8, 9, 10). The purpose of this proposal is to examine sex differences in the regulation and role of kappa-opioid receptors in mediating negative affective states in rats. Understanding the biological basis of these differences is crucial to developing better treatments for both men and women. Chartoff and colleagues have begun to examine the role of kappa-opioid receptors in males and females using intracranial self-stimulation (ICSS), an operant conditioning paradigm that is sensitive to increases or decreases in reward function "in real time". Kappa- opioid receptor agonists increase stimulation thresholds in ICSS, which is indicative of a decrease in reward function (anhedonia). Preliminary results show that females are less sensitive to the threshold-increasing effects of the kappa-opioid receptor agonist U50,488. Given that the majority of sex differences have been linked to actions of circulating gonadal steroid hormones, this proposal uses two complementary approaches to test the role of gonadal hormones in kappa-opioid receptor function. First, the effects of U50,488 on ICSS thresholds will be determined in gonadectomized rats. If gonadectomy abolishes the sex difference in the depressive-like effects of KOR activation, then it is likely that activational effects of gonadal steroid hormones are required. Although a fairly basic question, it is fundamental to the understanding of mood dysfunction in drug addiction. Second, the role of sex and gonadal steroid hormones on kappa-opioid receptor mRNA levels and U50,488-induced coupling to downstream effectors will be determined within brain regions that regulate reward function. If receptor levels or coupling are modulated by sex or sex hormones, then it is likely that differences in the behavioral effects of kappa-opioid receptor activation are due, in part, to receptor pharmacodynamics. Data from these studies will lead to a better understanding of how kappa-opioid receptors regulate affective states in males and females and will form a foundation for future research on sex differences in the role of kappa-opioid receptors in drug addiction.

描述（由申请人提供）：本R 03提案是针对PA-11-049“药物和酒精滥用/依赖中的女性和性别/性别差异”编写的。越来越多的证据表明，药物依赖的妇女表达更大的负面影响比男性（1，2，3，4）和负面的情绪状态，如压力和抑郁症更容易引发渴望和复发的妇女（5，6）。对男性的研究表明，厌恶和抑郁样状态部分由神经肽强啡肽介导，强啡肽是一种作用于κ阿片受体的内源性配体（7）。长期暴露于滥用药物促进强啡肽的合成和释放，这与抑郁样作用的出现是一致的（8，9，10）。本研究的目的是探讨大鼠中κ-阿片受体在介导负性情感状态中的调节和作用的性别差异。了解这些差异的生物学基础对于为男性和女性开发更好的治疗方法至关重要。Chartoff及其同事已经开始使用颅内自我刺激（ICSS）来研究κ阿片受体在男性和女性中的作用，ICSS是一种操作性条件反射范式，对“真实的时间”奖励功能的增加或减少敏感。κ-阿片样物质受体激动剂增加ICSS中的刺激阈值，这指示奖赏功能的降低（快感缺乏）。初步结果表明，女性对κ阿片受体激动剂U 50，488的阈值增加效应不太敏感。鉴于大多数性别差异与循环性腺类固醇激素的作用有关，该提案使用两种互补的方法来测试性腺激素在κ阿片受体功能中的作用。首先，将在性腺切除大鼠中确定U 50，488对ICSS阈值的影响。如果性腺切除消除了KOR激活的抑郁样效应的性别差异，那么很可能需要性腺类固醇激素的激活效应。虽然这是一个相当基本的问题，但它对于理解药物成瘾中的情绪功能障碍至关重要。第二，性和性腺类固醇激素对κ-阿片受体mRNA水平的作用以及U 50，488诱导的与下游效应物的偶联将在调节奖赏功能的大脑区域内确定。如果受体水平或偶联受性或性激素调节，那么κ-阿片受体激活的行为效应差异可能部分归因于受体药效学。这些研究的数据将使我们更好地了解卡帕阿片受体如何调节男性和女性的情感状态，并将为未来研究卡帕阿片受体在药物成瘾中作用的性别差异奠定基础。